REGENERX BIOPHARMACEUTICALS INC

SEC insider activity covers quarterly filings through June 30, 2026. Later filings are not included. Reported roles do not establish current employment or current holdings. SEC filing documents, sections and filing-text search cover filings dated January 1, 2000 onward. Earlier filings are deferred until after launch.

organization

SEC Insider

$43.4M

407 transactions

Summary

REGENERX BIOPHARMACEUTICALS INC is an organization.

Recent Insider Transactions

As filed, including amendments; not net cash flow or current holdings. Joint reports count once. Totals cover known values only.

Buys: $35.4MSales: $3.3M23 insiders

Date	Insider	Type	Value
2021-06-30	GOLDSTEIN ALLAN L	Buy	$25K
2023-07-03	Joint reporting: Essetifin SPA; CAVAZZA PAOLO; APTAFIN S P A; Cavazza Francesca; Cavazza Silvia; Cavazza Enrico; Cavazza Preta Martina	Buy	—
2023-07-03	Joint reporting: Essetifin SPA; CAVAZZA PAOLO; APTAFIN S P A; Cavazza Francesca; Cavazza Silvia; Cavazza Enrico; Cavazza Preta Martina	J	—
2022-05-17	FINKELSTEIN J J(President and CEO)	A	$0
2022-05-17	MCNAY JOSEPH C	A	$0
2022-05-17	Elsey R Don	A	$0
2022-05-17	Noseda Alessandro	A	$0
2022-05-17	Bove Mauro	A	$0
2022-05-17	GOLDSTEIN ALLAN L	A	$0
2021-12-08	GOLDSTEIN ALLAN L	G	$0
2021-08-02	FINKELSTEIN J J(President and CEO)	A	$0
2021-08-02	Bove Mauro	A	$0
2021-08-02	Noseda Alessandro	A	$0
2021-08-02	Elsey R Don	A	$0
2021-08-02	GOLDSTEIN ALLAN L	A	$0
2021-08-02	MCNAY JOSEPH C	A	$0
2021-06-30	GOLDSTEIN ALLAN L	Buy	$0
2021-06-30	GOLDSTEIN ALLAN L	Buy	$0
2021-06-30	FINKELSTEIN J J(President and CEO)	Buy	$0
2021-06-30	FINKELSTEIN J J(President and CEO)	Buy	$0

SEC filings: SEC EDGAR

Activity data: SEC EDGAR

REGENERX BIOPHARMACEUTICALS INC — Contributions, Lobbying & Contracts | Poliscope